Bioinformatics and cancer target discovery

Drug Discovery Today

Volumn 9, Issue 18, 2004, Pages 795-802

  Desany, Brian ^a   Zhang, Zemin ^a  

^a GENENTECH INC   (United States)

Author keywords

bioinformatics; cancer; Drug Discovery; expression profiling; genomic instability; SNPs; targets

Indexed keywords

CELL SURFACE MARKER; VASCULOTROPIN;

BIOINFORMATICS; CANCER GENETICS; DATA BASE; DNA MICROARRAY; DRUG DETERMINATION; DRUG RESEARCH; DRUG TARGETING; EXPRESSED SEQUENCE TAG; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC DAMAGE; GENOMICS; HUMAN; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SERIAL ANALYSIS OF GENE EXPRESSION; TUMOR SUPPRESSOR GENE;

ANALYSIS OF VARIANCE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS;

EID: 4444286756     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03224-6     Document Type: Review

References (56)

1. Green M.C., et al. Monoclonal antibody therapy for solid tumors. Cancer Treat. Rev. 26:2000;269-286
2. Futreal P.A., et al. A census of human cancer genes. Nat. Rev. Cancer. 4:2004;177-183
3. Altschul S.F., et al. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410
4. Eddy S.R. Profile hidden Markov models. Bioinformatics. 14:1998;755-763
5. Clark H.F., et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13:2003;2265-2270
6. Nielsen H., Krogh A. Prediction of signal peptides and signal anchors by a hidden Markov model. Proc. Int. Conf. Intel. Syst. Mol. Biol. 6:1998;122-130
7. Krogh A., et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:2001;567-580
8. LeCouter J., et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 412:2001;877-884
9. Leung Y.F., Cavalieri D. Fundamentals of cDNA microarray data analysis. Trends Genet. 19:2003;649-659
10. Golub T.R., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537
11. Wu T.D. Large-scale analysis of gene expression profiles. Brief. Bioinform. 3:2002;7-17
12. Eisen M.B., et al. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14863-14868
13. Tusher V.G., et al. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5116-5121
14. Alizadeh A.A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511
15. Quackenbush J. Genomics. Microarrays - guilt by association. Science. 302:2003;240-241
16. Ramaswamy S., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15149-15154
17. Brazma A., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29:2001;365-371
18. Detours V., et al. Integration and cross-validation of high-throughput gene expression data: comparing heterogeneous data sets. FEBS Lett. 546:2003;98-102
19. Editors. Editorial. Nucleic Acids Res. 32:2004;. W1
20. Zhang, Y. et al. GEPIS - quantitative gene expression profiling in normal and cancer tissues. Bioinformatics (in press)
21. Adams M.D., et al. Complementary DNA sequencing: expressed sequence tags and human genome project. Science. 252:1991;1651-1656
22. Boguski M.S., et al. dbEST-database for 'expressed sequence tags'. Nat. Genet. 4:1993;332-333
23. Brentani H., et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc. Natl. Acad. Sci. U. S. A. 100:2003;13418-13423
24. Scheurle D., et al. Cancer gene discovery using digital differential display. Cancer Res. 60:2000;4037-4043
25. Stekel D.J., et al. The comparison of gene expression from multiple cDNA libraries. Genome Res. 10:2000;2055-2061
26. Walker M.G., et al. Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. Genome Res. 9:1999;1198-1203
27. Velculescu V.E., et al. Serial analysis of gene expression. Science. 270:1995;484-487
28. Lash A.E., et al. SAGEmap: a public gene expression resource. Genome Res. 10:2000;1051-1060
29. Boon K., et al. An anatomy of normal and malignant gene expression. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11287-11292
30. Loging W.T., et al. Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res. 10:2000;1393-1402
31. Porter D., Polyak K. Cancer target discovery using SAGE. Expert Opin. Ther. Targets. 7:2003;759-769
32. Baudis M., Cleary M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics. 17:2001;1228-1229
33. Snijders A.M., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29:2001;263-264
34. Ishkanian A.S., et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat. Genet. 36:2004;299-303
35. Albertson D.G., et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25:2000;144-146
36. Pollack J.R., et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. U. S. A. 99:2002;12963-12968
37. Virtaneva K., et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1124-1129
38. Martinez-Climent J.A., et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 101:2003;3109-3117
39. Kluger Y., et al. Relationship between gene co-expression and probe localization on microarray slides. BMC Genomics. 4:2003;49
40. Zardo G., et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32:2002;453-458
41. Zaharieva B.M., et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J. Pathol. 201:2003;603-608
42. Harding M.A., et al. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res. 62:2002;6981-6989
43. Zhou Y., et al. Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis. Cancer Res. 63:2003;5781-5784
44. Glinsky G.V., et al. Common malignancy-associated regions of transcriptional activation (MARTA) in human prostate, breast, ovarian, and colon cancers are targets for DNA amplification. Cancer Lett. 201:2003;67-77
45. Levine A.J., et al. The p53 tumour suppressor gene. Nature. 351:1991;453-456
46. Hollstein M., et al. p53 mutations in human cancers. Science. 253:1991;49-53
47. Davies H., et al. Mutations of the BRAF gene in human cancer. Nature. 417:2002;949-954
48. Lynch T.J., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350:2004;2129-2139
49. Paez J.G., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 304:2004;1497-1500
50. Brett D., et al. EST analysis online: WWW tools for detection of SNPs and alternative splice forms. Trends Genet. 16:2000;416-418
51. Sherry S.T., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29:2001;308-311
52. Qiu P., et al. Genome wide in silico SNP-tumor association analysis. BMC Cancer. 4:2004;4
53. Johnson J.M., et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 302:2003;2141-2144
54. Modrek B., et al. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29:2001;2850-2859
55. Wang Z., et al. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res. 63:2003;655-657
56. Xu Q., Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 31:2003;5635-5643